Three on Three: Universal and High-Affinity Molecular Recognition of the Symmetric Homotrimeric Spike Protein of SARS-CoV-2 with a Symmetric Homotrimeric Aptamer.
Jiuxing LiZijie ZhangJimmy GuRyan AminiAlexandria G MansfieldJianrun XiaDawn WhiteHannah D StaceyJann C AngGurpreet PanesarAlfredo CaprettaCarlos D M FilipeKaren MossmanBruno J SalenaJonathan B GubbayCynthia BalionLeyla SoleymaniMatthew S MillerDeborah YamamuraJohn D BrennanYingfu LiPublished in: Journal of the American Chemical Society (2022)
Our previously discovered monomeric aptamer for SARS-CoV-2 (MSA52) possesses a universal affinity for COVID-19 spike protein variants but is ultimately limited by its ability to bind only one subunit of the spike protein. The symmetrical shape of the homotrimeric SARS-CoV-2 spike protein presents the opportunity to create a matching homotrimeric molecular recognition element that is perfectly complementary to its structural scaffold, causing enhanced binding affinity. Here, we describe a branched homotrimeric aptamer with three-fold rotational symmetry, named TMSA52, that not only possesses excellent binding affinity but is also capable of binding several SARS-CoV-2 spike protein variants with picomolar affinity, as well as pseudotyped lentiviruses expressing SARS-CoV-2 spike protein variants with femtomolar affinity. Using Pd-Ir nanocubes as nanozymes in an enzyme-linked aptamer binding assay (ELABA), TMSA52 was capable of sensitively detecting diverse pseudotyped lentiviruses in pooled human saliva with a limit of detection as low as 6.3 × 10 3 copies/mL. The ELABA was also used to test 50 SARS-CoV-2-positive and 60 SARS-CoV-2-negative patient saliva samples, providing sensitivity and specificity values of 84.0 and 98.3%, respectively, thus highlighting the potential of TMSA52 for the development of future rapid tests.
Keyphrases
- sars cov
- respiratory syndrome coronavirus
- binding protein
- protein protein
- gold nanoparticles
- amino acid
- endothelial cells
- copy number
- label free
- randomized controlled trial
- coronavirus disease
- clinical trial
- sensitive detection
- small molecule
- gene expression
- single molecule
- study protocol
- risk assessment
- capillary electrophoresis
- protein kinase